Shares of Seattle Genetics fell 5.18% to $134.87 at 12:25 EST on Tuesday, following the last session’s downward trend. NASDAQ Composite is falling 2.58% to $13,536.07, after two consecutive sessions in a row of losses. This seems, up to now, an all-around rough trend exchanging session today.
The company’s growth estimates for the present quarter and the next is a negative 408.3% and a negative 116.9%, respectively.
More news about Seattle Genetics.